(IN BRIEF) The Luxembourg Institute of Health has received a €35,000 donation from the non-profit Plooschter Project to support research by the Tumor–Stroma Interactions group within its Department of Cancer Research. The funding marks the seventh consecutive year of support … Read the full press release
Posted in Business, Education, Financial, Healthcare, Industrial, Investment, Luxembourg, Management, Marketing, Non Profit, Science, Technology
Tagged 000 Donation from Plooschter Project to Support Blood Cancer Research, Anne Largeot, biomedical research funding, chronic lymphocytic leukemia (CLL), community support for cancer research, Department of Cancer Research, Etienne Moussay, hematological cancer studies, Henri Grand Duke of Luxembourg, Jérôme Paggetti, leukemia research, Luxembourg Institute of Health, Luxembourg Institute of Health Receives €35, Luxembourg Institute of Health Strengthens Leukemia Research Through Long Term Partnership with Plooschter Project, lymphoma research, Plooschter Project, stem cell donor registry Luxembourg, tumor microenvironment research, Tumor Stroma Interactions group TSI
(IN BRIEF) Researchers at the Luxembourg Institute of Health have published a major review in Nature Cancer proposing a new framework to explain and potentially overcome the long-standing resistance of glioblastoma to immunotherapy. The study analyses how this aggressive brain … Read the full press release
Posted in Education, Healthcare, Industrial, Luxembourg, Management, Marketing, News, Pharma & Biotech, Science, Technology
Tagged brain cancer, cancer immunology, cancer research, Department of Cancer Research, glioblastoma, immune plasticity, immune resistance, immunotherapy, LIH, Luxembourg Institute of Health, Nature Cancer, Nature Cancer Review Reveals Why Immunotherapy Fails in Glioblastoma and How to Rethink Treatment, neuro-oncology, NORLUX Neuro-Oncology Laboratory, NORLUX Scientists Propose Immune Microenvironment Framework for Next-Generation Glioblastoma Therapies, oncology innovation, T cells, tumour microenvironment, tumour-associated macrophages
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?